Evidence map›Paper›PMID 26242933›Full record

ArticlePhysiological genomics2015

Role of the Na+/H+ exchanger 3 in angiotensin II-induced hypertension.

Xiao C Li, Gary E Shull, Elisa Miguel-Qin, Jia L Zhuo

Abstract read
In one paragraph

Article in Physiological genomics, 2015. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 27 papers.

0numbers the graph read from it
0cells of the map it votes in
27citing papers in PubMed
1.7field-weighted citation impact, top 16% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

27 citing papers in PubMed, 31 citations in OpenAlex.

  1. Article
  2. Article
  3. Article
  4. Review
  5. Genetic Deletion of ATInternational journal of molecular sciences · 2022
    Article
  6. Review
  7. Article
  8. Review
  9. The NaFrontiers in physiology · 2022
    Review
  10. Article
  11. Review
  12. Article
  13. Review
  14. Dietary fructose enhances angiotensin II-stimulated NaAmerican journal of physiology. Renal physiology · 2020
    Article
  15. Mechanisms of Metabolic Acidosis-Induced Kidney Injury in Chronic Kidney Disease.Journal of the American Society of Nephrology : JASN · 2020
    Article
  16. Proximal Tubule-Specific Deletion of the NHE3 (NaHypertension (Dallas, Tex. : 1979) · 2019
    Article
  17. Review
  18. Proximal Tubule-Specific Deletion of the NHE3 (NaHypertension (Dallas, Tex. : 1979) · 2018
    Article
  19. Article
  20. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

4 authors at 2 institutions in 1 country.

Xiao C LiLaboratory of Receptor and Signal Transduction, Department of Pharmacology and Toxicology; Division of Nephrology, Department of Medicine; University of Mississippi Medical Center, Jackson, Mississippi; and.
Gary E ShullDepartment of Molecular Genetics, University of Cincinnati College of Medicine, Cincinnati, Ohio.
Elisa Miguel-QinLaboratory of Receptor and Signal Transduction, Department of Pharmacology and Toxicology; Division of Nephrology, Department of Medicine; University of Mississippi Medical Center, Jackson, Mississippi; and.
Jia L ZhuoLaboratory of Receptor and Signal Transduction, Department of Pharmacology and Toxicology; Division of Nephrology, Department of Medicine; University of Mississippi Medical Center, Jackson, Mississippi; and jzhuo@umc.edu.
University of Mississippi Medical Center · USUniversity of Cincinnati Medical Center · US

Funding

Role of Intracrine Angiotensin II in Kidney CellsR01DK067299 · NIDDK · UNIVERSITY OF MISSISSIPPI MED CTR · PI Jia Long Zhuo · 2004 to 2026
$6.5M
Role of Proximal Tubule NHE3 in Angiotensin II-induced HypertensionR01DK102429 · NIDDK · UNIVERSITY OF MISSISSIPPI MED CTR · PI ZHUO, JIA LONG · 2014 to 2021
$2.5M
Novel Roles of Intracrine Angiotensin II in Proximal Tubule CellsR56DK067299 · NIDDK · HENRY FORD HEALTH SYSTEM · PI ZHUO, JIA LONG · 2009 to 2009
$352k
NIDDK NIH HHS 2R01DK-067299-06A2NIDDK NIH HHS R01 DK067299NIDDK NIH HHS R01 DK102429NIDDK NIH HHS R01DK-102429-01NIDDK NIH HHS R56 DK067299
6 · The paper itself

Abstract

The renal mechanisms responsible for angiotensin II (ANG II)-induced hypertension remain incompletely understood. The present study tested the hypothesis that the Na(+)/H(+) exchanger 3 (NHE3) is required for ANG II-induced hypertension in mice. Five groups of wild-type (Nhe3(+/+)) and Nhe3(-/-) mice were treated with vehicle or high pressor doses of ANG II (1.5 mg/kg/day ip, via minipump for 2 wk, or 10 pmol/min iv for 30 min). Under basal conditions, Nhe3(-/-) mice had significantly lower systolic blood pressure (SBP) and mean intra-arterial pressure (MAP) (P < 0.01), 24 h urine (P < 0.05), urinary Na(+) (P < 0.01) and urinary K(+) excretion (P < 0.01). In response to ANG II, SBP and MAP markedly increased in Nhe3(+/+) mice in a time-dependent manner, as expected (P < 0.01). However, these acute and chronic pressor responses to ANG II were significantly attenuated in Nhe3(-/-) mice (P < 0.01). Losartan blocked ANG II-induced hypertension in Nhe3(+/+) mice but induced marked mortality in Nhe3(-/-) mice. The attenuated pressor responses to ANG II in Nhe3(-/-) mice were associated with marked compensatory humoral and renal responses to genetic loss of intestinal and renal NHE3. These include elevated basal plasma ANG II and aldosterone and kidney ANG II levels, salt wasting from the intestines, increased renal AQP1, Na(+)/HCO3 (-), and Na(+)/K(+)-ATPase expression, and increased PKCα, mitogen-activated protein kinases ERK1/2, and glycogen synthase kinase 3αβ signaling proteins in the proximal tubules (P < 0.01). We concluded that NHE3 in proximal tubules of the kidney, along with NHE3 in intestines, is required for maintaining basal blood pressure as well as the full development of ANG II-induced hypertension.

Indexed as

AldosteroneAnesthesiaAngiotensin IIAnimalsBlood PressureElectrolytesHypertensionIntestinesKidneyKidney TubulesMaleMicePhenotypePhosphorylationPotassiumSignal TransductionAldosteroneAngiotensin IIElectrolytesPotassiumSodiumSodium-Hydrogen Exchangersangiotensin IIhypertensionintestineskidneyNHE3

Identifiers

PMID26242933
PMCPMC4593829
OpenAlexW2109192627

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.